Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Welfringer

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Pediatrics|March 11, 2026
Ruxolitinib and Tocilizumab for Child Bronchiolitis Obliterans After Toxic Epidermal NecrolysisLéa Jaume, Sophie Schmartz, Anne Welfringer-Morin, et al.
The British Journal of Dermatology|June 7, 2024
Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based studyThomas Bettuzzi, Anne Welfringer-Morin, Saskia Ingen-Housz-Oro, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 29, 2024
Drugs associated with epidermal necrolysis in children: A World Health Organization pharmacovigilance database analysisPauline Bataille, Benedicte Lebrun-Vignes, Thomas Bettuzzi, et al.
Medical Mycology Case Reports|February 21, 2017
A rare fungal infection: Phaehyphomycosis due to <i>Veronaea botryosa</i> and review of literatureAnne Welfringer, Valérie Vuong, Nicolas Argy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 26, 2025
Severe adverse drug reactions induced by lamotrigine: Are prescription guidelines being followed?Alice Thorn, Bénédicte Lebrun Vignes, Anne Welfringer-Morin, et al.
Journal of the American Academy of Dermatology|June 24, 2023
Respiratory complications in pediatric epidermal necrolysis: A retrospective study of 22 casesSophie Schmartz, Anne Welfringer-Morin, Muriel Le Bourgeois, et al.
Rheumatology (Oxford, England)|January 2, 2023
Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?Brigitte Bader-Meunier, Sylvain Breton, Darragh Duffy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 15, 2025
Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositisBenjamin Fournier, Jamie Sugrue, Anne Welfringer-Morin, et al.
The British Journal of Dermatology|July 6, 2023
Comparison of idiopathic and drug-induced epidermal necrolysis in childrenAnne Welfringer-Morin, Pauline Bataille, David Drummond, et al.
Rheumatology (Oxford, England)|September 1, 2025
Allogeneic hematopoietic stem cell transplantation for severe Still's disease: a retrospective report of 3 pediatric patientsMuriel Schmutz, Jade Cognard, Alice Hadchouel, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Pediatrics|March 11, 2026
Ruxolitinib and Tocilizumab for Child Bronchiolitis Obliterans After Toxic Epidermal NecrolysisLéa Jaume, Sophie Schmartz, Anne Welfringer-Morin, et al.
The British Journal of Dermatology|June 7, 2024
Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based studyThomas Bettuzzi, Anne Welfringer-Morin, Saskia Ingen-Housz-Oro, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 29, 2024
Drugs associated with epidermal necrolysis in children: A World Health Organization pharmacovigilance database analysisPauline Bataille, Benedicte Lebrun-Vignes, Thomas Bettuzzi, et al.
Medical Mycology Case Reports|February 21, 2017
A rare fungal infection: Phaehyphomycosis due to <i>Veronaea botryosa</i> and review of literatureAnne Welfringer, Valérie Vuong, Nicolas Argy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 26, 2025
Severe adverse drug reactions induced by lamotrigine: Are prescription guidelines being followed?Alice Thorn, Bénédicte Lebrun Vignes, Anne Welfringer-Morin, et al.
Journal of the American Academy of Dermatology|June 24, 2023
Respiratory complications in pediatric epidermal necrolysis: A retrospective study of 22 casesSophie Schmartz, Anne Welfringer-Morin, Muriel Le Bourgeois, et al.
Rheumatology (Oxford, England)|January 2, 2023
Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?Brigitte Bader-Meunier, Sylvain Breton, Darragh Duffy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 15, 2025
Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositisBenjamin Fournier, Jamie Sugrue, Anne Welfringer-Morin, et al.
The British Journal of Dermatology|July 6, 2023
Comparison of idiopathic and drug-induced epidermal necrolysis in childrenAnne Welfringer-Morin, Pauline Bataille, David Drummond, et al.
Rheumatology (Oxford, England)|September 1, 2025
Allogeneic hematopoietic stem cell transplantation for severe Still's disease: a retrospective report of 3 pediatric patientsMuriel Schmutz, Jade Cognard, Alice Hadchouel, et al.
Pageof 4